Ionis Pharmaceuticals (IONS) PT Lowered to $26 at Goldman Sachs

February 25, 2022 9:06 AM EST
Get Alerts IONS Hot Sheet
Price: $38.06 +2.81%

Rating Summary:
    9 Buy, 8 Hold, 4 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 4 | Down: 13 | New: 10
Join SI Premium – FREE
Goldman Sachs analyst Salveen Richter lowered the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $26.00 (from $30.00) while maintaining a Sell rating.

You May Also Be Interested In

Related Categories

Analyst PT Change